In this article Dr Chris Dalley, Consultant Haematologist University Hospital Southampton (NHS Foundation Trust), looks at the use of conventional and new Erythropoiesis Stimulating Agents (ESAs) in the treatment of MDS. What are Erythropoiesis Stimulating Agents (ESAs)? Erythropoiesis (from Greek ‘erythro’ meaning “red” and ‘poiesis’ meaning “to make”) is the process which produces red blood cells. More […]